Flagship explainer

What drives United Therapeutics Corporation’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity20%Tax burden78%net income ÷ pretax incomeInterest burden115%pretax ÷ operating incomeOperating margin47%operating income ÷ revenueAsset turnover0.42×revenue ÷ average assetsEquity multiplier1.13×average assets ÷ average equityAs of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
$1.3BFY2025
Income before tax$1.7BFY2025
Operating income$1.5BFY2025
$3.2BFY2025
Ending assets$7.9BFY2025
Beginning assets$7.4BFY2024
$7.1BFY2025
$6.4BFY2024
Source: · event Dec 31, 2025 · retrieved Sep 19, 2026 · annual-row source set
Embed this chart

View the full United Therapeutics Corporation analysis at Buy Like Buffett